is tirzepatide safe for fatty liver issue Tirzepatide, a dual GIP/GLP-1 receptor agonist, alleviates metabolic dysfunction-associated steatotic disease by reducing the expression of CD36 and OBP2A Ever-Rising Fatty Liver Disease Gets

Appetite suppression : By reducing hunger and promoting a feeling of fullness, GLP-1 helps you stick to a healthier eating plan

Individuals with type 2 diabetes and concurrent obesity represent the primary population who might benefit from these effects, particularly when weight reduction could improve multiple cardiovascular risk factors simultaneously

There is increased risk in patients whose ability to maintain blood pressure has already been compromised by a reduced blood volume or concurrent administration of certain CNS depressant drugs (e.g., phenothiazines or general anesthetics) [see PRECAUTIONS

Theres a weight-loss plateau